Vitiligo is a common skin disease characterized by idiopathic progressive skin hypomelanosis. Vitiligo is associated with several comorbid autoimmune diseases such as localized scleroderma. This article demonstrates the general development mechanism of these pathologies, as well as the key aspect of cross-effect between autoimmune diseases on the molecular level. Recently, dermatologists have noted the increasing number of patients suffering from combined pathologies. Such patients (in pediatrics) have torpid course of disease and no pathognomonic symptoms. That exaggerates the diagnostics and adequate therapy prescription. This leads to increased awareness among physicians of different specialties on possible combinations, clinical present...
The autoimmune basis of segmental vitiligo (SV) has only recently been recognized. Systemic autoimmu...
Localized scleroderma (LS) is a complex disease characterized by a mixture of inflammation and fibro...
Vitiligo is an acquired immune-mediated disorder of pigmentation clinically characterized by well-de...
Multiple auto-immune syndrome is defined by the coexistence of at least three different autoimmune d...
Autoimmune diseases of dermatological interest can be classified as organ-specific and systemic. The...
Segmental vitiligo and generalized vitiligo are in general considered to be separate entities. The a...
Segmental vitiligo (SV) and segmental morphea are unilateral cutaneous disorders, with an autoimmune...
Vitiligo is an acquired hypomelanotic disorder characterized by depigmented macules resulting from t...
Background : Recent clinical and animal experimental studies postulate that the pathogenetic mechani...
Vitiligo represents the most common cause of acquired skin, hair, and oral depigmentation, affecting...
Vitiligo is the most common depigmentation disorder where the selective destruction of functioning m...
Vitiligo is the most common depigmentation disorder where the selective destruction of functioning m...
The localized scleroderma (LS) known as morphea, presents a variety of clinical manifestations that ...
Vitiligo is a chronic stigmatizing disease, already known for millennia, which mainly affects melano...
Autoimmune skin disorders include autoimmune bullous diseases, collagen vascular diseases, alopecia ...
The autoimmune basis of segmental vitiligo (SV) has only recently been recognized. Systemic autoimmu...
Localized scleroderma (LS) is a complex disease characterized by a mixture of inflammation and fibro...
Vitiligo is an acquired immune-mediated disorder of pigmentation clinically characterized by well-de...
Multiple auto-immune syndrome is defined by the coexistence of at least three different autoimmune d...
Autoimmune diseases of dermatological interest can be classified as organ-specific and systemic. The...
Segmental vitiligo and generalized vitiligo are in general considered to be separate entities. The a...
Segmental vitiligo (SV) and segmental morphea are unilateral cutaneous disorders, with an autoimmune...
Vitiligo is an acquired hypomelanotic disorder characterized by depigmented macules resulting from t...
Background : Recent clinical and animal experimental studies postulate that the pathogenetic mechani...
Vitiligo represents the most common cause of acquired skin, hair, and oral depigmentation, affecting...
Vitiligo is the most common depigmentation disorder where the selective destruction of functioning m...
Vitiligo is the most common depigmentation disorder where the selective destruction of functioning m...
The localized scleroderma (LS) known as morphea, presents a variety of clinical manifestations that ...
Vitiligo is a chronic stigmatizing disease, already known for millennia, which mainly affects melano...
Autoimmune skin disorders include autoimmune bullous diseases, collagen vascular diseases, alopecia ...
The autoimmune basis of segmental vitiligo (SV) has only recently been recognized. Systemic autoimmu...
Localized scleroderma (LS) is a complex disease characterized by a mixture of inflammation and fibro...
Vitiligo is an acquired immune-mediated disorder of pigmentation clinically characterized by well-de...